Christoph A Klein Selected Research

Immunotherapy

3/2010	Expression of melanoma-antigen-A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancer.
8/2002	The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph A Klein Research Topics

Disease

38	Neoplasms (Cancer) 11/2023 - 04/2002
9	Neoplasm Metastasis (Metastasis) 11/2020 - 09/2008
9	Melanoma (Melanoma, Malignant) 02/2020 - 01/2004
7	Breast Neoplasms (Breast Cancer) 03/2021 - 09/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2008
4	Circulating Neoplastic Cells 11/2014 - 10/2013
3	Disease Progression 11/2023 - 01/2005
3	Lung Neoplasms (Lung Cancer) 11/2023 - 02/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2020
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 04/2009
2	Carcinoma (Carcinomatosis) 01/2005 - 08/2002
1	Glioblastoma (Glioblastoma Multiforme) 03/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2020
1	Esophageal Squamous Cell Carcinoma 01/2014
1	Fibrosarcoma 07/2009
1	Adenocarcinoma of Lung 09/2008
1	Adenocarcinoma 09/2008
1	Sezary Syndrome (Sezary Erythroderma) 09/2008
1	Mycosis Fungoides 09/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2008
1	Esophageal Neoplasms (Esophageal Cancer) 05/2008
1	Hematologic Neoplasms (Hematological Malignancy) 08/2002

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2008
4	SuspensionsIBA 11/2023 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 05/2008
4	AntigensIBA 04/2012 - 08/2002
3	Keratins (Keratin)IBA 11/2023 - 09/2005
3	Epithelial Cell Adhesion MoleculeIBA 11/2023 - 12/2014
3	Cell-Free Nucleic AcidsIBA 01/2022 - 02/2020
3	Messenger RNA (mRNA)IBA 04/2012 - 01/2004
3	RNA (Ribonucleic Acid)IBA 07/2005 - 08/2002
2	AntibodiesIBA 11/2023 - 08/2005
2	MART-1 AntigenIBA 01/2019 - 08/2005
2	LigandsIBA 04/2018 - 08/2002
2	Dicyclohexylcarbodiimide (DCCD)IBA 01/2018 - 02/2014
2	Keratin-19 (Keratin 19)IBA 03/2010 - 07/2005
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA 03/2021
1	gluconic acid (gluconate)FDA LinkGeneric 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Nucleic AcidsIBA 02/2020
1	68Ga-pentixaforIBA 04/2018
1	UbiquitinIBA 04/2018
1	Therapeutic UsesIBA 01/2018
1	Progesterone FDA LinkGeneric 12/2016
1	Cyclin D1IBA 10/2014
1	antineoplaston A10 (A 10)IBA 02/2014
1	IntegrinsIBA 01/2014
1	Thymidine KinaseIBA 03/2011
1	CollagenIBA 07/2009
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 07/2009
1	Matrix Metalloproteinases (MMPs)IBA 09/2008
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 09/2008
1	Metalloproteases (Metalloproteinases)IBA 09/2008
1	Chondroitin Sulfate ProteoglycansIBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2004
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 08/2002
1	Minor Histocompatibility AntigensIBA 08/2002
1	Peptides (Polypeptides)IBA 08/2002

Therapy/Procedure

20	Therapeutics 11/2022 - 04/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 07/2005
2	Immunotherapy 03/2010 - 08/2002
1	Drug Therapy (Chemotherapy) 01/2014
1	Life Support Care 03/2011
1	Heterologous Transplantation (Xenotransplantation) 02/2009
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2008
1	Neoadjuvant Therapy 07/2005
1	Stem Cell Transplantation 08/2002